Sotigalimab (APX 005) is a monoclonal antibody targeting CD40 with potential antitumor activity and can be used to study metastatic pancreatic cancer and melanoma.
Purity:
98.50%
CAS Number:
[2305607-45-6]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted